Related Experiment Video

Updated: May 23, 2026

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

Preclinical Remodeling of Human Prostate Cancer through the PTEN/AKT Pathway

Marco A De Velasco1, Hirotsugu Uemura

  • 1Department of Urology, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka 589-8511, Japan.

Advances in Urology
|March 29, 2012
PubMed

Insights

Genetically modified mouse models incorporating PTEN loss, common in advanced prostate cancer, are crucial for personalized medicine. These models aid in developing new drugs and validating cancer biomarkers.

Area of Science:

  • Oncology
  • Genetics
  • Translational Medicine

Background:

  • Prostate cancer progression is linked to genetic and epigenetic changes.
  • PTEN (phosphatase and tensin homolog) loss is associated with advanced human prostate cancer.

Purpose of the Study:

  • To discuss the development of genetically modified mouse (GEM) models for prostate cancer research.
  • To highlight the role of PTEN knockout mouse models in understanding tumor development and progression.
  • To outline the utility of these models in personalized medicine, drug discovery, and biomarker validation.

Main Methods:

  • Reviewing the evolution of PTEN knockout mouse models.
  • Analyzing the cooperative effects of PTEN loss with other genetic alterations in prostate cancer.
  • Discussing the application of these models in translational research.

Main Results:

  • PTEN haploinsufficiency and homozygous loss are significant in prostate cancer.
  • GEM models are being engineered to replicate human prostate cancer's molecular defects.
  • PTEN alterations cooperate with other genetic changes to drive tumor development.

Conclusions:

  • PTEN knockout mouse models are valuable tools for prostate cancer research.
  • These models are instrumental in developing personalized medicine approaches.
  • They serve as platforms for target identification, biomarker validation, and drug discovery in prostate cancer.

More Related Videos

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...